GHGuardant Health, Inc.
$177.80+1.75%
0.7% Above PivotData as of Oct 2, 2026
Loading theme radar
Biotech & Healthcare Stocks
Large-cap pharma, gene editing, medical devices, life sciences tools, and AI-driven drug discovery across the healthcare stack.
3M Return+5.5%
YTD Return+26.7%Year to date
vs SPY (3M)+7.1%Theme minus SPY
Total Stocks46Curated universe
Setup Distribution
Breaking Out2
Near Pivot6
Forming5
Total Setups13
Theme vs SPY (3M)
Biotech & Healthcare Stocks+10.2%
SPY+3.1%
Top Setups in Biotech & Healthcare Stocks(3 of 13 shown)
Open theme screener
BIIBBiogen Inc.
$219.88-1.32%
2.6% To PivotData as of Oct 2, 2026
HUMHumana Inc.
$388.36+2.29%
6.4% To PivotData as of Oct 2, 2026
Unlock all 13 setups in Biotech & Healthcare Stocks
See every active, near-pivot, and forming setup with full charts, advanced filtering, historical performance, alerts, and much more.
All setups and full details Advanced filters & sorting Real-time alerts & notifications
After your 7-day trial: $10/month billed annually ($120/year), or $15/month. No credit card required. No charge unless you upgrade.
Today in Biotech & Healthcare Stocks
Data as of Oct 3, 2026Theme Performance
| Today (1D) | +0.04% |
| 5D | -1.92% |
| 1M | -1.90% |
| 3M | +5.48% |
| YTD | +26.66% |
| 1Y | +37.65% |
| vs SPY Benchmark | |
| Today (1D) | -0.69% |
| 1M | -1.44% |
| YTD | +13.80% |
Top Movers
Theme News
AbbVie joins US government pilot to test drug discount rebates
reuters.com · 10h ago$ABBV
How Much Does a 58-Year-Old Need Invested to Replace a $160,000 Salary With Dividends?
247wallst.com · 11h ago$ABBV
Can ABBV's New Parkinson's Pill Strengthen Its Neuroscience Franchise?
zacks.com · 15h ago$ABBV
Setup coverage is limited to 3 free previews. Rows marked Pro are outside this preview. Unlock Pro to see setup coverage across all 46 stocks.
| # | Ticker | Company | Price | % Change | RS Rating | Market Cap | Setups | Status | Watch |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Humana Inc. | $388.36 | +2.33% | 91 | $46.63B | (1) | Forming | ||
| 2 | Biogen Inc. | $219.88 | -1.32% | 79 | $32.49B | (1) | Near Pivot | ||
| 3 | Guardant Health, Inc. | $177.80 | +1.75% | 91 | $23.58B | (1) | Breaking Out | ||
| 4 | Eli Lilly and Company | $1,142.85 | -0.74% | 70 | $1.08T | Pro | Pro | ||
| 5 | AbbVie Inc. | $262.82 | +1.07% | 79 | $464.35B | Pro | Pro | ||
| 6 | Merck & Co., Inc. | $144.30 | +0.35% | 82 | $356.4B | Pro | Pro | ||
| 7 | UnitedHealth Group Incorporated | $371.90 | +1.83% | 66 | $337.74B | Pro | Pro | ||
| 8 | Thermo Fisher Scientific Inc. | $654.80 | +0.35% | 83 | $243.34B | Pro | Pro |
About Biotech & Healthcare Stocks
US biotech and healthcare stocks screened by market data, analyst coverage, and pipeline depth — large-cap pharma, gene therapy, medical devices, and AI-driven drug discovery.
46 StocksIn this theme
13 SetupsAcross 3 states
Updated DailyAfter market close (~8PM ET)
Popular Segments in this theme
Financial Data & Software Notice: VCP Scanner is an educational financial research database and stock screening software platform. VCP Scanner does not generate, recommend, or package trade decisions, buy/sell signals, or personalized investment advice. Theme baskets are quantitative metric rules, not managed funds or portfolio recommendations. See our Terms of Service and Privacy Policy.